IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.
HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.
RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.
© 2026 Blank Capital Research. All rights reserved. System Version: Aegis V8 (God Mode).
Downward pressure identified in IVP. The 10.0% decline correlates with broader sector weakness.
The Company owns and operates veterinary hospitals throughout the United States. The Company specializes in small animal general practice hospitals which serve all manner of companion pets, emphasizing canine and feline breeds. Inspire Veterinary Partners, Inc. 780 Lynnhaven Parkway Suite 400 Virginia Beach, Virginia.
Agriculture, Forestry, And Fishing
Agriculture
$5.97M
Kimball Carr
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
X-AXIS: EV/EBITDA (LOWER = CHEAPER) | Y-AXIS: ROE (HIGHER = ELITE) | RED CIRCLE = IVP ANALYSIS TARGET
| Stock | Rating | Score▼ | Quality | Value | Momentum | P/E | EV/EBITDA | ROE | ROA | Gross Mgn | Op Mgn | Net Mgn | Rev Growth | Div Yield | D/E | Mkt Cap | AUDIT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
$DOLE Dole plc | 72 | 84 | 93 | 52 | - | - | 10.0% | 3.2% | 8.5% | 3.3% | 1.7% | 2.8% | 2.4% | 73.0x | $1.3B | VS | |
$CVGW CALAVO GROWERS INC | 64 | 85 | 73 | 59 | 24.8x | 14.4x | 9.7% | 6.7% | 9.8% | 3.0% | 3.1% | -2.0% | 3.6% | 0.0x | $393M | VS | |
$AVO Mission Produce, Inc. | 63 | 78 | 76 | 63 | 15.0x | 7.6x | 6.8% | 4.1% | 11.6% | 4.7% | 2.9% | 12.7% | 0.0% | 21.0x | $814M | VS | |
$VFF Village Farms International, Inc. | 60 | 70 | 71 | 80 | 8.4x | 4.4x | 20.1% | 13.3% | 47.9% | 24.5% | 15.8% | 21.5% | 0.0% | 12.0x | $353M | VS | |
$ORIS ORIENTAL RISE HOLDINGS Ltd | 60 | 64 | 34 | 88 | - | - | 3.1% | 3.0% | 26.2% | 13.9% | 13.9% | -37.8% | 0.0% | 0.0x | $19M | VS | |
$AGRO Adecoagro S.A. | 56 | 51 | 50 | 44 | - | - | 6.9% | 2.9% | 9.4% | 2.2% | 6.1% | 3.4% | 3.6% | 0.0x | $1000M | VS | |
$FDP FRESH DEL MONTE PRODUCE INC | 54 | 48 | 47 | 71 | - | - | -3.8% | -3.8% | 7.9% | -2.1% | -2.8% | 0.2% | 3.3% | 9.0x | $1.7B | VS | |
$CTVA Corteva, Inc. | 53 | 41 | 45 | 65 | - | 41.6x | -6.0% | -5.1% | 37.2% | -11.5% | -12.2% | 12.6% | 1.0% | 17.0x | $45.9B | VS | |
$BV BrightView Holdings, Inc. | 52 | 70 | 70 | 37 | 12.3x | 3.8x | 3.1% | 1.7% | 23.3% | 5.0% | 2.1% | -3.4% | 0.0% | 61.0x | $1.3B | VS | |
$ALCO ALICO, INC. | 49 | 11 | 29 | 86 | - | 3.3x | -81.0% | -49.1% | -436.2% | -462.7% | -334.7% | -5.5% | 0.6% | 83.0x | $265M | VS | |
$IVP INSPIRE VETERINARY PARTNERS, INC. | 27 | 31 | 23 | 0 | - | - | -169.8% | -39.3% | 18.2% | -45.6% | -58.5% | 6.6% | 0.0% | 330.0x | $6M | ||
| SECTOR BENCH | - | - | - | - | - | 11.1x | 6.6x | 3.1% | 2.3% | 18.2% | 2.2% | 2.1% | 1.5% | 0.0% | 0.2x | - | REF |
INSPIRE VETERINARY PARTNERS, INC. (IVP) receives a "Avoid" rating with a composite score of 26.8/100. It ranks #4697 out of 7,333 stocks in our coverage universe and carries a 1-star rating. Ratings are driven by a 6-factor quantitative model measuring quality, value, momentum, investment, stability, and short interest.
Sign in to join the discussion.
Kimball Carr
Chief Executive Officer
31
26
23
Audit Verdict: Lower quality and stability scores may indicate governance concerns.
No recent insider transactions available for IVP
Lagging peers — losers tend to keep underperforming
Expensive relative to fundamentals — limited margin of safety
Weak fundamentals — higher risk of value trap
High volatility — wider range of outcomes increases timing risk
Aggressive spending — empire-building risk, dilutive growth
Below-average composite — caution warranted
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Relative valuation derived from Agriculture, Forestry, And Fishing sector benchmarks. Model weights: EV/EBITDA (40%), P/B (35%), P/S (25%). Re-calculated daily.
No analyst ratings for IVP.
View All RatingsYOY expansion rate
Core pricing power
Operating efficiency
Bottom-line conversion
Equity capital efficiency
Asset base utilization
Financial leverage load
Direct cash return
Material decline in asset turnover efficiency detected
| Factor | Global | Sector | Tilt |
|---|---|---|---|
| PROFITABILITY | 31 | 25 | +6ALPHA |
| MOMENTUM | 0 | 0 | 0NEUTRAL |
| VALUATION | 23 | 13 | +10ALPHA |
| INVESTMENT | 26 | 31 | -5NEUTRAL |
| STABILITY | 23 | 13 | +10ALPHA |
| SHORT INT | 59 | 81 | -22DRAG |
Global = full universe. Sector = relative to industry peers. Positive tilt indicates idiosyncratic strength.
ROE proxy -169.8% (sector 3.1%)
GM 18% vs sector 18%, OM -46% vs sector 2%
Capital turnover N/A
Rev growth 7%, 3yr history
Interest coverage N/A
Composite assessment of profitability, capital efficiency, and financial strength. Top-tier entities demonstrate sustainable cash flow generation and elite competitive moats.
Profit generated per dollar of shareholder equity
Efficiency of asset utilization
Pricing power and cost efficiency
Core business profitability
Bottom-line profitability
The Quality factor evaluates the persistence and magnitude of realized cash flows. Companies with scores >70 exhibit superior pricing power and structural financial resilience through diverse economic regimes.
Our uncertainty rating tracks the predictability of future cash flows and potential for permanent capital loss. Moderate visibility with standard industry cyclicality.
Our quantitative model flags INSPIRE VETERINARY PARTNERS, INC. with an Avoid rating, assigning a composite score of 26.8/100 and 1 out of 5 stars. Ranked #4697 of 7,333 stocks, IVP falls in the bottom tier across key factors. Historically, stocks with this profile have faced elevated risk of underperformance and capital loss.
IVP's quality score of 31/100 is below average, suggesting challenges with profitability or capital efficiency. The company reports a return on equity of -169.8% (sector avg: 3.1%), gross margins of 18.2% (sector avg: 18.2%), net margins of -58.5% (sector avg: 2.1%). Investors should examine whether management is actively addressing these weaknesses or if they reflect structural industry headwinds.
IVP registers a value score of just 23/100, suggesting the stock trades at a significant premium to its fundamental metrics. Key valuation metrics include a P/B ratio of 1.43x. High-premium valuations like this require strong future execution to avoid multiple compression, and downside risk is elevated if growth disappoints.
INSPIRE VETERINARY PARTNERS, INC.'s investment score of 26/100 suggests limited reinvestment activity. Key growth metrics include revenue growth of 6.6% vs. a sector average of 1.5% and a return on assets of -39.3% (sector: 2.3%). While this can be positive for mature, cash-generative businesses returning capital to shareholders, it may also signal a lack of growth opportunities or management conservatism.
INSPIRE VETERINARY PARTNERS, INC. is experiencing notably weak momentum with a score of just 0/100. The stock has underperformed its peers and is trending below major moving averages. Revenue growth stands at 6.6% year-over-year. While deep momentum weakness can occasionally present value opportunities, it often reflects deteriorating fundamentals or structural headwinds that may persist.
INSPIRE VETERINARY PARTNERS, INC. registers a low stability score of 23/100, indicating high volatility and potentially stressed financial conditions. Key stability metrics include a debt-to-equity ratio of 330.00x (sector avg: 0.2x). Stocks at this level carry elevated capital loss risk and may be unsuitable for conservative portfolios without careful risk management.
The short interest score of 59/100 for IVP suggests somewhat elevated bearish positioning by institutional traders. Specific risk factors include elevated leverage (D/E: 330.00x), micro-cap liquidity risk. With a $6M market cap (micro-cap), INSPIRE VETERINARY PARTNERS, INC. may experience above-average volatility. Investors should consider whether the short thesis has merit or if it creates a potential short-squeeze opportunity.
INSPIRE VETERINARY PARTNERS, INC. is a micro-cap company in the Agriculture, Forestry, And Fishing sector, ranked #16 of 17 in its sector (6th percentile) and #4697 of 7,333 overall (36th percentile). Key comparisons include ROE of -169.8% trailing the 3.1% sector median and operating margins of -45.6% below the 2.2% sector average. This bottom-quartile standing highlights significant competitive headwinds within the Agriculture, Forestry, And Fishing space.
While IVP currently exhibits a AVOID profile, superior opportunities exist within the AGRICULTURE, FORESTRY, AND FISHING sector. Our model identifies several "Strong Buy" candidates with higher quality scores and more attractive valuations among direct industry competitors.
View Top Agriculture, Forestry, And Fishing Alpha →Quant Factor Profile
Upgrade catalyst
Improvement in Momentum (0) would have the largest impact on the composite score.
RANK #16 OF 17 IN CONSUMER STAPLES
ROE 5518% BELOW SECTOR MEDIAN
Gross Margin IN LINE WITH SECTOR BENCHMARKS
Op. Margin 2200% BELOW SECTOR MEDIAN
AUDIT DATA AS OF SEP 30, 2025 (Q2 FY2025)
We rate INSPIRE VETERINARY PARTNERS, INC. (IVP) as Avoid with a composite score of 26.8/100 at a current price of $0.03. The stock falls in the bottom quintile of our universe across key quantitative factors, and the multi-factor weakness suggests a high probability of continued underperformance.
The rating is primarily driven by strength in quality (31th percentile) and investment (26th percentile), which together account for the majority of the composite score. Offsetting weakness in momentum (0th percentile) and value (23th percentile) tempers our overall conviction. We assign a No Moat rating (16/100), Very High uncertainty, and Poor capital allocation.
Key items to watch: momentum to confirm whether the current price trend has legs; balance sheet deleveraging progress; the path to profitability. Any material change in these dynamics could warrant a reassessment of our rating. The moat trend is stable, which suggests the competitive landscape is stable for now.
INSPIRE VETERINARY PARTNERS, INC. holds a lower-quartile position (#16 of 17) within the Agriculture, Forestry, And Fishing sector, based on our composite quantitative scoring across quality, value, momentum, and stability factors. The composite score of 26.8/100 places it at rank #4697 in our full 7,333-stock universe. At $6M in market capitalization, INSPIRE VETERINARY PARTNERS, INC. is a small-cap player in the Agriculture, Forestry, And Fishing space, which limits certain scale advantages but may allow for more agile strategic execution.
Revenue is growing at 7%, though momentum at the 0th percentile suggests the market has not yet fully recognized this trajectory. This potential disconnect between fundamental improvement and market recognition could represent an opportunity for patient investors if the growth trend persists.
The margin cascade tells an important story: gross margins of 18% (0.0pp vs sector) narrow to operating margins of -46% (-47.8pp vs sector) and net margins of -58.5%, yielding a gross-to-net conversion rate of -321%. The significant margin erosion from gross to net suggests elevated operating expenses, high interest costs, or other structural drags that warrant monitoring.
At a current price of $0.03, INSPIRE VETERINARY PARTNERS, INC. is trading at a premium to fundamental value. Our value factor score of 23/100 reflects a composite assessment across multiple valuation metrics including price-to-earnings, price-to-book, EV/EBITDA, and price-to-sales ratios relative to both sector peers and the broader market. The premium valuation implies the market is pricing in significant future growth or quality improvements that are not yet fully reflected in current fundamentals.
The stock currently trades at P/B of 1.4x, P/S of 0.3x. We evaluate these multiples in the context of both absolute levels and sector-relative positioning to form our valuation view.
The stock may offer contrarian value if near-term headwinds prove transitory — the current weakness in factor scores may reverse if business fundamentals stabilize.
The Avoid rating (composite 26.8/100) reflects multi-factor weakness, and historically, stocks in this scoring range have underperformed the market by a meaningful margin.
Elevated leverage (330% D/E) amplifies downside risk and limits management's financial flexibility in adverse scenarios.
Thin net margins of -58.5% provide limited cushion against cost pressures, competitive pricing, or macroeconomic headwinds — even small changes in costs could swing the company to a loss.
Weak momentum (0th percentile) suggests institutional selling pressure and unfavorable technical dynamics that may persist.
We assign a Very High uncertainty rating to INSPIRE VETERINARY PARTNERS, INC.. The stock exhibits multiple compounding risk factors: significant leverage (330% debt-to-equity), current negative profitability (net margin -58.5%), below-average price stability (23th percentile). The extreme uncertainty around future cash flows makes precise valuation difficult, and the range of outcomes is exceptionally wide. Only investors with high risk tolerance and extended time horizons should consider this name.
Specific risk factors that inform our assessment include: significant leverage (330% debt-to-equity); current negative profitability (net margin -58.5%); below-average price stability (23th percentile); weak quality scores (31th percentile). Each of these factors independently widens the distribution of potential outcomes, and in combination they create a risk profile that demands careful position sizing. The stability factor at the 23th percentile and quality factor at the 31th percentile provide a quantitative summary of the overall risk landscape.
We identify limited risk mitigants at this time, which contributes to our very high uncertainty assessment. Investors should monitor for improvement in balance sheet metrics, margin stability, and business predictability that could warrant a downgrade in our risk assessment over time.
We rate INSPIRE VETERINARY PARTNERS, INC.'s capital allocation as Poor. Key concerns include low returns on equity (-169.8%), elevated leverage (330% D/E), negative profitability, weak asset returns (ROA -39.3%). Exemplary capital allocators generate ROE above 20% and maintain conservative leverage — INSPIRE VETERINARY PARTNERS, INC. significantly underperforms these benchmarks, raising questions about management's ability to create shareholder value.
Investors should scrutinize management's reinvestment decisions and balance sheet trajectory before committing capital. Poor capital allocation often compounds over time: overlevered balance sheets limit strategic flexibility, while low returns on capital destroy shareholder value. We would need to see sustained improvement in profitability metrics and balance sheet discipline before considering an upgrade.
In summary, INSPIRE VETERINARY PARTNERS, INC. receives a Avoid rating with a composite score of 26.8/100 (rank #4697 of 7,333). Our quantitative framework assigns a No Moat (16/100, trend: stable), Very High uncertainty, and Poor capital allocation. The average factor score across quality, value, momentum, stability, and investment is 21/100.
Our analysis does not support a constructive view on INSPIRE VETERINARY PARTNERS, INC. at this time. The combination of limited competitive advantages, very high uncertainty, and poor capital allocation suggests unfavorable risk-reward at current levels. We recommend investors avoid new positions and existing holders consider reducing exposure.
Analysis derived from Blank Capital Research quantitative terminal. For informational purposes only. No trade solicitation. Past performance not indicative of future results. Consult a qualified advisor.
We do not assign INSPIRE VETERINARY PARTNERS, INC. a meaningful economic moat, scoring 16/100 on our composite assessment. Current fundamentals do not demonstrate the kind of durable competitive advantages — such as superior returns on invested capital, margin superiority, or reinvestment efficiency — that would protect the company from competitive erosion over the long term. The highest-scoring pillar, margin superiority, reached only 6.5/20.
The strongest moat sources are margin superiority (6.5/20) and growth durability (4.7/20). GM 18% vs sector 18%, OM -46% vs sector 2%. Rev growth 7%, 3yr history. These pillars form the core of INSPIRE VETERINARY PARTNERS, INC.'s competitive identity and are the primary drivers of excess returns in our framework.
Areas of relative weakness include reinvestment efficiency (0/20) and economic value creation (2.5/20). Capital turnover N/A. Improvement in these areas could meaningfully widen the moat over time, while deterioration would be an early warning of competitive erosion.
Our moat trend assessment is Stable. Multi-year ROIC and operating margin trajectories show neither meaningful improvement nor deterioration, suggesting the competitive position is steady. We expect INSPIRE VETERINARY PARTNERS, INC.'s moat profile to remain largely unchanged absent a material shift in return on capital or industry dynamics.
Key profit drivers include moderate revenue growth of 7%. The margin cascade from 18% gross to -46% operating to -58.5% net reveals the company's cost structure and reinvestment intensity. Our analysis indicates that profit quality raises some durability concerns, with the quality factor at the 31th percentile.
The margin profile shows gross margins of 18%, operating margins of -46%, net margins of -58.5%. Return metrics include ROE of -169.8% and ROA of -39.3%. Relative to the Agriculture, Forestry, And Fishing sector, gross margins are 0.0 percentage points below the sector median of 18%, and ROE of -169.8% compares to a sector median of 3.1%.
The balance sheet reflects high leverage with D/E of 330%, which may limit financial flexibility, revenue growth of 7%. The sector median D/E is 0%, putting INSPIRE VETERINARY PARTNERS, INC. at higher leverage than the typical peer. Elevated leverage in combination with the current margin profile warrants close monitoring for any deterioration in debt-servicing capacity.
Below-average quality (31th percentile) raises durability concerns about the fundamental profile and increases the risk of negative earnings surprises.
Above 50MA
37.18%
Net New Highs
+51081
Unfortunately for some shareholders, the Inspire Veterinary Partners, Inc. ( NASDAQ:IVP ) share price has dived 61% in...
Paramount Global shares jumped 7.5% in pre-market trading after the company announced a $28 billion merger deal with Skydance Media to create a new entity called 'New Paramount'. Several other stocks also saw significant pre-market movements.
Several healthcare stocks saw significant price movements in Thursday's pre-market session, with notable gainers including Autonomix Medical, Inspire Veterinary, and Salarius Pharmaceuticals, while Gain Therapeutics, Senti Biosciences, and Aspira Womens Health declined.
Shares of Ulta Beauty, Inc. (NASDAQ: ULTA) fell sharply during Wednesday’s session amid the company's presentation at the J.P. Morgan Retail Roundup investor conference where the company reportedly issued a weak outlook. Ulta Beauty shares dipped 13.7% to $448.08 on Wednesday. Here are some other stocks moving in today's mid-day session. Gainers ARCA biopharma, Inc. (NASDAQ: ABIO) climbed 108% to $3.5549 after the company and Oruka Therapeutics announced a merger agreement. Kintara Therapeutics, Inc. (NASDAQ: KTRA) shares gained 89% to $0.1906 after the company entered a merger agreement with TuHURA Biosciences. Next Technology Holding Inc. (NASDAQ: NXTT) rose 57.4% to $6.42. Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) shares climbed 39.3% to $5.45. Vanda Pharmaceuticals' Fanapt® received U.S. FDA approval for the acute treatment of Bipolar I Disorder. VivoPower International PLC (NASDAQ: VVPR) shares gained 39% to $8.20 after the company declared a capital management strategy including a stock buyback program of up to $5 million. Next.e.GO N.V. (NASDAQ: EGOX) gained 32.7% to $0.0345. XTI Aerospace, Inc. (NASDAQ: XTIA) rose 32.2% to $4.63. BestGrowthStocks.com issued comprehensive evaluation of XTI Aerospace, Inc. Brooge Energy Limited (NASDAQ: BROG) gained 28.8% to $3.0790. Addex Therapeutics Ltd (NASDAQ: ADXN) rose 24.6% to $16.21 after the company and funds affiliated with Perceptive Advisors announced the launch of Neurosterix. Aesthetic Medical International Holdings Group Limited (NASDAQ: AIH) gained 24.3% to $0.3981 after gaining 13% on Tuesday. LAMF Global Ventures Corp. I (NASDAQ: LGVC) gained 22.7% to $13.21. ViewLAMF Global Ventures Corp. I shareholders approved previously announced business combination with Nuvo Group Ltd. Quhuo Limited (NASDAQ: QH) rose 21.7% to $0.6501 after reporting unaudited financial results for the second half and full year 2023. Destiny Tech100 Inc. (NYSE: DXYZ) gained 21.4% to $25.77. OneMedNet Corporation (NASDAQ: ONMD) gained 21.2% to $0.9600. OneMedNet announced it entered a securities purchase agreement dated Mar. 28 providing up to $4.54 million in funding through private placement ...
Though crowded, the identity management market seems eager for new solutions, and Venice is finding traction.